Back to search

Sentcell Ltd

12021050

active
ltd
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

54 5 Sloane Avenue, London, SW3 3DL
Incorporated 29/05/2019

Compliance

Last accounts

30/04/2025

micro entity

Next accounts due

31/01/2027

On track

Confirmation statement

Last: 17/10/2025

Due 31/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr. Alessio Lanna

director · Since 29/05/2019

DIRECTOR

ITALIAN · MONACO · Age 39

Mr Michael Eric Elalouf

director · Since 14/08/2021

DIRECTOR

FRENCH,BRITISH · UNITED KINGDOM · Age 39

Professor Derek William Gilroy

director · Since 09/01/2025

HEAD, DEPT. OF AGEING, RHEUM & REG UCL

IRISH · ENGLAND · Age 57

Also on 1 other board

Alessio Lanna

director · Since 29/05/2019

Italian · Monaco · Age 39

Michael Eric Elalouf

director · Since 14/08/2021

French,British · United Kingdom · Age 39

Derek William Gilroy

director · Since 09/01/2025

Irish · England · Age 57

Former

Francesca Bottari

director · Resigned 10/05/2026

Persons with Significant Control

Dr. Alessio Lanna

25–50% shares
75–100% votes
Appoint directors

Italian · Monaco · Age 39

54, 5 Sloane Avenue, London, SW3 3DL

Notified 29/05/2019

Mr. Brendan Francis Blumer

25–50% shares

Chinese · Cayman Islands · Age 39

54, 5 Sloane Avenue, London, SW3 3DL

Notified 03/11/2025

Mr. Jacopo Moretti

Significant control

Italian · Monaco · Age 41

54, 5 Sloane Avenue, London, SW3 3DL

Notified 19/12/2025

Change History

officer appointed → ELALOUF, Michael Eric
2026-06-17
officer appointed → GILROY, Derek William, Professor
2026-06-17
officer appointed → LANNA, Alessio, Dr.
2026-06-17
post town → London
2026-06-17

LONDON

status → active
2026-06-17

Active

postcode → SW3 3DL
2026-06-17

SW3 3EL

type → ltd
2026-06-17

Private Limited Company

address line1 → 54 5 Sloane Avenue
2026-06-17

607 SLOANE AVENUE

CompanyRankvs 660+ SIC 72110 peers
69

Financial strength97th percentile among SIC peers · 24/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 135.96× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
660Sentcell Ltd
69
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/04/2025

Net Worth

£4.5M

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£1.3M

Working capital

Current Assets

£1.3M

Current Liabilities

£10k

Fixed Assets

£3.2M

0avg. employees

Balance Sheet

Assets less current liabilities£4.5M
Prepared with Companies House

EstimatesDerived

YearCurrent RatioImplied Profit
2025135.96-£364k
2024—-£687k
2023—-£561k
2022—-£4k
2021—+£5.8M

Derived from filed accounts. Not audited figures.